超越承诺:评估和减轻CRISPR基因编辑中的非目标效应,以获得更安全的治疗方法
1Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Centre Basel, F Hoffmann-La Roche Ltd., Basel, Switzerland.
Frontiers in bioengineering and biotechnology
|February 23, 2024
概括
基因编辑CRISPR为状细胞等遗传疾病提供了革命性的治疗方法. 然而,确保CRISPR的安全性需要强大的方法来检测在临床使用之前的意外遗传改变.
科学领域:
- 生物技术是生物技术.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 基因编辑技术CRISPR已经迅速发展,彻底改变了对遗传疾病的药物开发.
- 第一个基于CRISPR的治疗状细胞病和β-血病标志着一个重要的里程碑.
- 来自CRISPR活动的意外遗传变化对患者安全和治疗开发构成风险.
研究的目的:
- 审查和总结检测由CRISPR-Cas核酶引起的非目标和目标改变的方法.
- 讨论CRISPR诱导的遗传变化的各种检测方法的优点和局限性.
- 为突出提高CRISPR基因编辑系统安全性的策略.
主要方法:
- 审查关于CRISPR非目标和目标评估技术的现有文献.
- 基于其敏感性,特异性和适用性的不同方法的比较分析.
- 讨论关于CRISPR疗法的临床前风险评估的监管考虑.
主要成果:
- 为了检测意外的CRISPR-Cas核酶活性,存在各种各样的方法.
- 每种方法都有独特的优点和局限性,影响其在安全评估中的实用性.
- 提高CRISPR系统安全性的策略对于治疗开发至关重要.
结论:
- 准确评估CRISPR诱导的基因变异对于安全的治疗应用至关重要.
- 了解方法的局限性是选择适当的安全评估策略的关键.
- 该审查为CRISPR疗法目前的监管环境中提供了对临床前风险评估的见解.
相关概念视频
CRISPR
51.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.0K
What is Genetic Engineering?
74.1K
Overview
74.1K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K
Homologous Recombination
50.5K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.5K


